Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics

Detailed scientific analysis of antiviral pipeline identifies most promising clinical compounds aligned with 100 Days Mission global preparedness recommendations CAMBRIDGE, Mass., April 29, 2024 /PRNewswire/ -- Building on its commitment to identify strengths and gaps in the R&D pipeline for ant...

2024-04-29 12:00 1019

Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024

MELBOURNE, Australia, April 29, 2024 /PRNewswire/ -- Prota Therapeutics' CEO ProfessorMimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards. Professor Tang's exceptional work as a lead researcher for the Murdoch Children's Research Institute (MCRI) an...

2024-04-29 10:40 1105

New Business Opportunities in the Silver Economy-Many overseas companies participate in China's largest senior care show

SHANGHAI, April 29, 2024 /PRNewswire/ -- On January 15, China's State Council issued "Opinions on Developing the Silver Economy and Improving the Welfare of the Elderly," which aims to promote the "silver economy," a series of economic activities, including the provision of products and services ...

2024-04-29 10:00 1013

OBiO Technology will showcase at American Society of Gene & Cell Therapy

-Visit OBiO Tech booth #1644 at American Society of Gene & Cell Therapy in Maryland,USA SHANGHAI, April 28, 2024 /PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene therapy, will showcase...

2024-04-29 00:00 1063

OBiO Technology will showcase at American Society of Gene & Cell Therapy

MGI Tech opens Customer Experience Center in Brazil to contribute to the advancement of genomics in Latin America

The laboratory has state-of-the-art technology to support medical research of clinical labs and healthcare institutions, improving precision diagnoses and treatments. The agricultural sector can also benefit SÃO PAULO, April 28, 2024 /PRNewswire/ -- Contributing to the advancement of genomics in...

2024-04-28 17:54 1031

Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome

CASTRES, France, April 26, 2024 /PRNewswire/ -- Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSA™ (vibegron under the international non-propriet...

2024-04-26 23:46 2073

United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%

Along with the publication of its 2023 annual report and the Q1 2024 report, United Imaging Healthcare released its ESG report. SHANGHAI, April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, h...

2024-04-26 23:00 1704

United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™

SHANGHAI, April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility, intern...

2024-04-26 23:00 1667

New President Appointed for Nitto Denko Avecia Inc.

MILFORD, Mass., April 26, 2024 /PRNewswire/ -- Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of N...

2024-04-26 21:20 1635

Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC

SUZHOU, China, April 26, 2024 /PRNewswire/ -- Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a grou...

2024-04-26 21:00 1103

Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers

* The second DMC review recommends the continuation of dose escalation in the clinical trial as per protocol. * The interim safety assessment was based on the review of safety data from 18 metastatic gastrointestinal cancer patients, including patients that have tolerated multiple doses of ca...

2024-04-26 21:00 1148

FOSUN FOR GOOD, CREATING IMPACT: Fosun International Issued its 2023 ESG Report and the Second Climate Information Disclosures Report

HONG KONG, April 26, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today issued the Environmental, Social and Governance (ESG) Report 2023 (the "ESG Report"). Facing the increasingly sever...

2024-04-26 19:34 2324

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

KYOTO, Japan, April 26, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko,Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection, and ...

2024-04-26 16:00 1377

Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa

SHANGHAI, April 26, 2024 /PRNewswire/ -- World Malaria Day is marked each year onApril 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly endanger...

2024-04-26 12:39 1001

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

* CBL-514 is the first product to treat cellulite at the raised areas. * Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034. * CBL-0201EFP Phase 2 study demonstrated CBL-514 sta...

2024-04-26 01:25 1070

2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor

SHANGHAI, April 25, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented in an ...

2024-04-25 22:00 950

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

* "Aiming to offer a Dengue antiviral treatment course in $100 price range" * Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Biosc...

2024-04-25 21:41 1112

On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference

* miLab showed almost equivalent to WHO-certified first-degree microscopy experts: Sensitivity of 94.4%, Specificity of 98.1% * African authority on malaria diagnosis said "miLab is a potential game changer in accelerating access to parasitological confirmation" YONGIN, South Korea, April 25,...

2024-04-25 21:00 1197

On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference

Antengene Announces One Oral and Three Poster Presentations at ASCO 2024

* Oral session：ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in Phase II studies for cervical cancer * Three Poster presentations: Phase I/II studies for ATG-031 (anti-CD24 monoclonal antibody) and ATG-022 (Claudin 18.2 antibody-drug conjugate) and selinexor(XPO1 Inhibitor) SHANGHA...

2024-04-25 20:00 1629

Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD)

SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD)...

2024-04-25 19:57 1620

1 234 5 6 ... 808